Amy Seal
Psychiatric/Mental Health · Seymour, TNNPI 1477171627
Payments from drug & device makers
Across 133 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$450
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$434
- AbbVie$364
- Supernus Pharmaceuticals, Inc.$270
- Neurocrine Biosciences, Inc.$191
- Lundbeck LLC$178
- plus $580 from 10 others
What the payments were for
- Food & beverage$2,468100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $450 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $434 |
| AbbVie | 23 | $364 |
| Supernus Pharmaceuticals, Inc. | 20 | $270 |
| Neurocrine Biosciences, Inc. | 5 | $191 |
| Lundbeck LLC | 20 | $178 |
| Teva Pharmaceuticals USA, Inc. | 7 | $131 |
| Corium, LLC | 4 | $88 |
| Johnson & Johnson | 5 | $74 |
| Alkermes, Inc. | 4 | $73 |
| Vanda Pharmaceuticals Inc. | 4 | $69 |
| Sunovion Pharmaceuticals Inc. | 3 | $48 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Indivior Inc. | 1 | $22 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$125
- CAPLYTA$123
- ABILIFY MAINTENA$117
How this compares
$2,468 in reported general payments places this provider in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 18 | $31,879 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 66 | $9,841 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 16 | $5,010 |
| Hydroxyzine Hcl | 62 | $887 |
| Aripiprazole | 55 | $785 |
| Clomipramine Hcl | 12 | $552 |
| Fluoxetine Hcl | 57 | $524 |
| Mirtazapine | 25 | $375 |
| Buspirone Hcl | 24 | $360 |
| Clonazepam | 25 | $304 |
| Duloxetine Hcl | 39 | $273 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $270 |
| Lamotrigine | 29 | $265 |
| Trazodone Hcl | 48 | $259 |
| Sertraline Hcl | 68 | $258 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $434 | $31,87918 claims |
| Indivior Inc.Suboxone | $22 | $5,01016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Seymour
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
- Kristian DambrinoNashville$449K
- Mary AllenMemphis$422K
- Lauren HansenNashville$263K
- Joshua ThompsonChattanooga$262K
- Kristal HurstBlaine$260K
- Kaitlynn EarlsGreeneville$228K
- Tory WoodardCookeville$191K
- Sarah VogelfangerMemphis$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.